AGIC Capital has acquired 100% of Slovenia-based medical equipment supplier Fotona as part of a plan to expand operations in Asia with an emphasis on China. The deal will facilitate an exit for US private equity firm The Gores Group.
SDIC Fund Management, a GP under China’s State Development & Investment Corporation, has led a $65 million round of funding for CanSino Biologics, a China-based vaccine developer.
New Frontier, a private equity firm co-founded by Antony Leung (pictured), formerly Hong Kong's financial secretary, has invested in Best Unimed Medical Group, a Shenzhen-based third-party physicians group.
Lok Capital has led a $10 million Series A round of funding for Indian diabetes care provider Dr. Mohan’s Diabetes Specialities Centre.
A consortium led by True North Managers will buy a majority stake in India’s Religare Health Insurance (RHI) for INR10.4 billion ($162 million).
Having turned down Kerala Institute of Medical Sciences once due to potential conflicts of interest, True North moved quickly to deploy $200 million when presented with a second opportunity to invest in the hospital chain
Mahindra Partners has led a $21 million Series B round for Indian home healthcare start-up Medwell Ventures, operator of Nightingales Home Health Services.
Sequoia Capital India has made its debut investment in an Australia-based start-up, leading a A$26.7 million ($20.2 million) Series C round of funding for HealthEngine, an online healthcare marketplace.
Redpoint Ventures and Sinovation Ventures have led a Series B round worth RMB100 million ($14 million) for Xiaolu Clinic, a traditional Chinese medicine (TCM) online services provider.
Indian private equity firm True North - formerly known as India Value Fund Advisors (IVFA) - has invested $200 million in domestic hospital chain Kerala Institute of Medical Sciences (KIMS).
Chinese healthcare-focused GP HighLight Capital, which was set up by Steven Wang, formerly of CDH Investments, is targeting $250 million for its second US dollar-denominated fund.
The South Korean government has pledged to establish a KRW113.5 billion ($102 million) fund to support life science start-ups through related ecosystem and infrastructure investments.
Singapore-based private equity firm Gateway Partners has agreed to invest S$70 million ($50.2 million) in distressed local hospital operator Healthway Medical.
China healthcare-focused GP C-Bridge Capital and Tasly Holding, a traditional Chinese medicine business, have agreed to invest $150 million in a newly-created entity formed through the merger of two local pharmaceutical companies.
Eight Roads decided to leverage the development of China’s healthcare sector by building a hospital, but addressing the various challenges that come with a greenfield strategy requires very patient capital
Suzhou Ribo Life Science, a Chinese drug developer that focuses on liver diseases, has raised a RMB270 million ($40 million) Series B round led by SDIC Fund Management.
TA Associates has invested in Indian pharmaceutical product supplier Ideal Cures. Neither the size of the commitment nor the size of the GP's stake in the company were disclosed.
The Innovation Network Corporation of Japan (INCJ) has teamed up with two pharmaceutical players to invest JPY10 billion ($87 million) in the creation of a biotech spin-out. INCJ will hold a 70.5% stake in the company.
Healthcare-focused PE investor Ally Bridge Group will support the HK$2.3 billion ($301 million) management-led take-private of Hong Kong-listed Shandong Luoxin Pharmacy Group.
Singapore’s EDBI and Philips have formally launched an Asia-focused investment platform that targets companies in digital healthcare services.
Integrated Healthcare Holdings (IHH), which is majority-owned by Malaysian sovereign wealth fund Khazanah Nasional, has sold part of its stake in India's Apollo Hospitals for INR10.7 billion ($160 million).
Hospital Corporation of China (HCC), a hospital operation group established by Hony Capital, has launched a Hong Kong IPO that would see the company raise as much as HK$500 million ($64 million).
Indian healthcare testing firm iGenetic Diagnostics has raised INR1.3 billion ($19.9 million) from UK-based development finance institution (DFI) CDC Group and Indian conglomerate Manipal Education & Medical Group.
Beijing-based Anxin Doctor, a mobile app focused on pediatric and women's healthcare, has completed a RMB200 million ($29 million) Series B round of funding across two tranches.